IP Library Patent Application 11578152
Patent Application
App. No. 11/578,152

Anti-Inflammatory Analgesic External Aqueus Liquid Preparation

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/578,152
Abstract

An anti-inflammatory analgesic external aqueous liquid preparation that excels in percutaneous absorbability and applicability, and being stable over time. There is provided an anti-inflammatory analgesic external aqueous liquid preparation comprising diclofenac or its salt, a dibasic acid ester, a lower alcohol, and 0.05 to 0.45 wt % of thickening agent.

Claims (7)

1 . An anti-inflammatory analgesic external aqueous liquid preparation comprising diclofenac or its salt, a dibasic acid ester, a lower alcohol, and 0.05 to 0.45 wt % of thickening agent.

2 . The anti-inflammatory analgesic external aqueous liquid preparation according to claim 1 , containing 0.1 to 20 wt % of the diclofenac or its salt, 0.5 to 20 wt % of the dibasic acid ester, and 10 to 80 wt % of the lower alcohol.

3 . The anti-inflammatory analgesic external aqueous liquid preparation according to claim 1 or 2 , wherein the salt of diclofenac is diclofenac sodium or diclofenac ammonium.

4 . The anti-inflammatory analgesic external aqueous liquid preparation according to any one of claims 1 to 3 , wherein the dibasic acid ester is diisopropyl adipate, diisopropyl sebacate, or diethyl sebacate.

5 . The anti-inflammatory analgesic external aqueous liquid preparation according to any one of claims 1 to 4 , wherein the lower alcohol is ethyl alcohol and/or isopropyl alcohol.

6 . The anti-inflammatory analgesic external aqueous liquid preparation according to any one of claims 1 to 5 , wherein the thickening agent is hydroxy propyl cellulose and/or hydroxy ethyl cellulose.

7 . The anti-inflammatory analgesic external aqueous liquid preparation according to any one of claims 1 to 6 , wherein the pH is in the range of 5 to 8.5.

Assignments (2)
SECURITY AGREEMENT Recorded Feb 2, 2010
From: CERIMON PHARMACEUTICALS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 023882/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2007
From: KAWAMURA, YUTAKA; FUJITA, ITSURO
To: DOJIN IYAKU-KAKO CO., LTD.
Reel/Frame 019561/0584 →